Procurement

NHS Branded Medicines Tranche A - NOFE and Midlands & East and Natalizumab for London & SOFE - 1 September 2026

  • NHS England

Procurement identifier (OCID): ocds-h6vhtk-051c98

Description

NHS Branded Framework Agreement - Lot 1 - Tranche A for the North of England and Midlands & East.

Period of Framework Agreement: 1st September 2026 to 31st August 2028 with an option or option(s) to extend (at the authority's discretion for a further 24 months.

Lot 2 - Natalizumab for London and South of England. The period of Framework Agreement: 1st September 2026 to 31st August 2027 with an option or option(s) to extend for a further 12 months.

Notices

UK7: Contract details notice

Notice identifier
2026/S 000-068603
Published
21 July 2026, 11:16am

UK6: Contract award notice

Notice identifier
2026/S 000-064847
Published
9 July 2026, 3:45pm
Show all versions Hide all versions

UK4: Tender notice

Notice identifier
2026/S 000-023990
Published
17 March 2026, 12:14pm

UK2: Preliminary market engagement notice

Notice identifier
2026/S 000-023102
Published
13 March 2026, 3:08pm
Show all versions Hide all versions

UK1: Pipeline notice

Notice identifier
2025/S 000-029473
Published
3 June 2025, 12:41pm
Show all versions Hide all versions